SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is trending as intense public debate surrounds a recent controversial shooting involving federal agents in Minneapolis. This incident has sparked highly polarized discussions across social media regarding government actions, constitutional rights, and broader political tensions, significantly influencing sentiment around this politically associated company.

Zoracles

Zoracles ($ZORA) is trending as the crypto community anticipates a significant market reversal and "ALT token coin season," driven by upcoming catalysts like the "Clarity Act," potential FED rate cuts, and government actions influencing broader market liquidity. Many investors are "loading up" and expressing strong conviction in its long-term growth, despite some recent stagnant price action. The token is closely watched for its correlation with Bitcoin's movements and its potential within the creator economy on Coinbase's Base app.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending, driven by its robust, culture-first community on the Solana blockchain, which champions steady progress and long-term holding. Positive sentiment is fueled by ongoing discussions about future project developments and the broader 'green wave' cultural movement within the cannabis and hemp sector.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth (USAR) is generating significant buzz following news of a substantial government investment from the U.S., driving community excitement around a potentially much higher implied valuation and short squeeze opportunities. Further discussions highlight French government backing for a new rare earth facility in Europe, underscoring USAR's expanding role in securing critical mineral supply chains and reducing reliance on foreign sources.

Kraken Robotics, Inc. engages in the design, manufacture, and sale of software-centric sensors, subsea batteries, thrusters and underwater robotic systems. It operates through the following geographical segments: Asia Pacific, Europe, Middle East and Africa, North America, and Other. The company was founded on May 14, 2008, and is headquartered in Mt. Pearl, Canada.

Kraken Robotics Inc

Kraken Robotics is currently trending due to strong financial performance and recent significant battery contracts, underscoring its pivotal role in advanced autonomous underwater vehicles. Community excitement is driven by its strategic partnership with defense tech giant Anduril and the anticipated NASDAQ uplisting, which many believe will significantly enhance its market visibility and growth trajectory within the subsea defense sector.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

MannKind is actively discussed as a significant FDA decision on Afrezza's dose conversion label update is anticipated, a key event expected to simplify use and drive adoption. This, alongside recent record quarterly revenue and upcoming regulatory milestones for pediatric Afrezza and a Furoscix autoinjector, fuels community debate on the company's growth potential and prospects for a major revaluation or M&A. While many foresee a pivotal year for MannKind, skepticism persists among others regarding management's ability to translate these opportunities into sustained stock performance.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently a hot topic in the crypto community, driven by significant ETF inflows and growing institutional interest that signal strong confidence. Investors are actively staking for yield and strategically accumulating during market dips, highlighting the platform's expanding utility in DeFi and a surging stablecoin market cap. Its robust ecosystem continues to attract new projects and discussions, reinforcing Solana's position as a leading force in the digital asset landscape.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is trending amidst a notable downturn, with community conversation heavily debating whether prevailing "AI fears" are an existential threat or an exaggerated market reaction. While many highlight the company's strong fundamentals and consistent share buybacks, the stock's movement reflects a broader negative sentiment impacting the SaaS sector. Investors are actively discussing if this marks a generational buying opportunity or a deeper structural challenge for the creative software giant.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as renewed geopolitical interest in Greenland's abundant critical mineral resources, especially rare earths, fuels intense speculation. The community is highly bullish, anticipating significant upside for CRML's Tanbreez heavy rare earth deposit and a sector-wide short squeeze as the Western world seeks to establish independent rare earth supply chains. This comes amid discussions of U.S. investment in the sector and CRML's own strategic partnerships for processing.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull (BULL) is trending as the community debates whether its current trading range represents a strong base for a potential reversal, with many highlighting technical support and absorption of selling pressure. Investors are optimistic about the company's platform strength and profitability, comparing it favorably to other fintech brokers, yet some express frustration over persistent selling pressure and historical price action. The ongoing discussion centers on its valuation, potential decoupling from crypto market sentiment, and expectations around future growth drivers.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bright Minds Biosciences Reports Phase 2 BMB-101 Data: 73% Median Drop in Absence Seizures on EEG

Bright Minds Biosciences (NASDAQ:DRUG) reported top-line results from an open-label Phase 2 breakthrough study evaluating BMB-101 in adults with highly refractory absence seizures and developmental...

Bright Minds Biosciences (NASDAQ:DRUG) Price Target Raised to $147.00

BTIG Research upped their price objective on Bright Minds Biosciences from $72.00 to $147.00 and gave the stock a "buy" rating in a research note on Tuesday...

Bright Minds Biosciences (NASDAQ:DRUG) Hits New 12-Month High - What's Next?

Bright Minds Biosciences (NASDAQ:DRUG) Sets New 52-Week High - Time to Buy...

Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday

<ul class="summary-bullets"><li>The trial had 24 patients, exceeding the original target of 20, and included a 4-week baseline.</li><li>In the Absence cohort, patients experienced a median 73.1% reduction in seizures.</li><li>The DEE cohort saw a median 63.3% decrease in major motor seizures.</li></ul>Shares of Bright Minds Biosciences Inc. (DRUG) rose over 51% on Tuesday morning, after the company announced promising topline results from its Phase 2 BREAKTHROUGH trial evaluating BMB-101.BMB-101 is a selective 5-HT2C biased agonist, in adults with drug-resistant Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE). The study met its primary goals, showing strong reductions in seizure frequency while maintaining a favorable safety profile.<h2 class="st-heading-2">Trial And Participants</h2>The trial had 24 patients, exceeding the original target of 20, and included a 4-week baseline, 4-week titration, and maintenance period consisting of&nbsp;2 weeks for the Absence cohort and 4 weeks for the DEE cohort.&nbsp;Participants were heavily pretreated, with a median of 3 anti-seizure medications in the Absence cohort and 5 in the DEE cohort, having failed multiple prior therapies.&nbsp;On Stocktwits, retail sentiment around the&nbsp;<a href="https://stocktwits.com/symbol/DRUG">stock</a> jumped to ‘extremely bullish’ from ‘bearish’ territory. Message volume improved to ‘extremely high’ from ‘low’ levels in 24 hours.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_01_06_085410_png_a041b522e5.webp" alt="DRUG’s Sentiment Meter and Message Volume as of 09:35 a.m. ET on Jan. 6, 2026 | Source: Stocktwits" width="924" height="102"><figcaption>DRUG’s Sentiment Meter and Message Volume as of 09:35 a.m. ET on Jan. 6, 2026 | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">Seizure Reduction</h2>In the Absence cohort, patients experienced a median 73.1% reduction in seizures lasting more than or equal to three seconds and a 74.4% decrease in total seizure time over 24 hours.&nbsp;The DEE cohort, including patients with Lennox-Gastaut Syndrome (LGS), Dravet syndrome, and Rett syndrome, saw a median 63.3% decrease in major motor seizures. LGS patients achieved a 60.3% reduction, while other DEE participants experienced a 76.1% reduction.&nbsp;Beyond seizure control, BMB-101 increased REM sleep by 90%, from 56.2 to 106.7 minutes, without altering total sleep duration.DRUG stock has gained over 93% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-arwr-stock-surge-pre-market-today/cmxwuZ6R4TS">Why Did ARWR Stock Surge Over 15% Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Technician Reads Eeg Data While Subjecting The Boy To A Variety Of Visual And Respiratory Stimuli Stroboscopy.

Why Did DRUG Stock Rocket 51% Today?

The Phase 2 BREAKTHROUGH trial met its primary goals, showing strong reductions in seizure frequency while maintaining a favorable safety profile.

Equity

The Phase 2 BREAKTHROUGH trial met its primary goals, showing strong reductions in seizure frequency while maintaining a favorable safety profile.


Bright Minds Biosciences (NASDAQ:DRUG) Trading Down 5.7% - Time to Sell?

Bright Minds Biosciences (NASDAQ:DRUG) Trading Down 5.7% - Should You Sell...

Chardan Capital Reaffirms Buy Rating for Bright Minds Biosciences (NASDAQ:DRUG)

Chardan Capital reiterated a "buy" rating and issued a $80.00 price target on shares of Bright Minds Biosciences in a research note on Friday...

HC Wainwright Has Negative Outlook for DRUG Q1 Earnings

Bright Minds Biosciences Inc. (NASDAQ:DRUG - Free Report) - Stock analysts at HC Wainwright reduced their Q1 2026 EPS estimates for shares of Bright Minds Biosciences in a research report issued on...

Bright Minds Biosciences (NASDAQ:DRUG) Trading 4.2% Higher - Here's Why

Bright Minds Biosciences (NASDAQ:DRUG) Trading Up 4.2% - Time to Buy...

Bright Minds Biosciences (NASDAQ:DRUG) Sees Unusually-High Trading Volume - Time to Buy?

Bright Minds Biosciences (NASDAQ:DRUG) Sees Large Volume Increase - Here's What Happened...

Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company was founded by Ian B. McDonald and Alan P. Kozikowski on May 31, 2019 and is headquartered in Chicago, IL.

Bright Minds Biosciences Inc

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

DRUG
Bright Minds Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest DRUG News

DRUGBright Minds Biosciences Inc